Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
KURN | Switzerland | CHF | Delayed | |
CSBTF | OTC Markets | USD | Delayed |
Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold to be implanted in any intervertebral disc space or posterolateral spine level; and Magnetos Flex Matrix, an open matrix bone graft. Its Fibrin-PTH pipeline products comprise KUR-111 and KUR-113 that are in Phase 2b clinical trials for trauma indications; KUR-113 that is in Phase 2a clinical trial for spinal indications. The company was incorporated in 2016 and is headquartered in Schlieren, Switzerland.
Name | Age | Since | Title |
---|---|---|---|
Clemens A. van Blitterswijk | 64 | 2017 | Chairman |
Faheem A. Sandhu | - | 2018 | Member of Strategic Advisory Board |
Kornelis Poelstra | - | 2018 | Member of Strategic Advisory Board |
Richard Allen | - | 2018 | Member of Strategic Advisory Board |
Andrew A. Sama | - | 2018 | Member of Strategic Advisory Board |
Thomas Cha | - | 2022 | Member of Strategic Advisory Board |
Alpesh A. Patel | - | 2018 | Member of Strategic Advisory Board |
W.R Walsh | - | 2018 | Member of Strategic Advisory Board |
Norbert Boos | - | - | Member of Advisory Board |
Ralph Müller | - | - | Member of Advisory Board |
Cato T. Laurentin | - | - | Member of Advisory Board |
Thomas Steffen | - | - | Member of Advisory Board |
Joost D. de Bruijn | 58 | 2017 | President of Innovation and Strategy & Executive Director |
Oliver Walker | 55 | 2018 | Independent Non-Executive Director |
Christopher T. Fair | 54 | 2022 | CEO & Director |
Albert Arp | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review